A recent article in the New York Times, How Poor Sleep Affects Your Risk of Dementia, summarizes some recent findings showing both excessively short and long sleep, as well as…
Read More
Ahmad Sajjadi, MD, PhD, was interviewed on NBCLA yesterday evening about the news that former LA County Sheriff Lee Baca who lives with Alzheimer’s disease, wandered away from his home.…
Read More
Message from the Director Dear Friends of UCI MIND, Please enjoy the latest issue of MIND Matters from UCI MIND. In this Spring issue, we highlight a number of…
Read More
Today, the US Food and Drug Administration granted full clinical approval to Eli Lilly to market donanemab, brand name KISUNLA, for the treatment of early Alzheimer’s disease, including Mild Cognitive…
Read More
A June 17 article in the Los Angeles Times highlighted an important safety risk associated with the new class of medications recently approved for treating Alzheimer’s disease (https://www.latimes.com/science/story/2024-06-17/alzheimers-drug-has-potent...
Read More
Today, the FDA convened its Peripheral and Central Nervous System Drugs Advisory Committee to review the data from pivotal clinical trials of donanemab, a monoclonal antibody against the beta amyloid…
Read More
UCI News highlighted a newly published study led by Bryce Mander, PhD, a UCI MIND faculty member and associate professor of psychiatry and human behavior, showing a link between sleep…
Read More
Associate Professor of Neurobiology and Behavior and UCI MIND faculty member, Elizabeth Chrastil, PhD, is featured in a Wall Street Journal article about studying her own brain in an MRI…
Read More
The UC Irvine School of Medicine recognized the 2024 best mentors and Elizabeth Head, PhD, Professor and Vice Chair of Research in the Department of Pathology and Laboratory Medicine was…
Read More
For patients experiencing cognitive decline due to Alzheimer’s Disease (AD), choosing the most appropriate treatment course at the right time is of great importance. A key element to these decisions…
Read More